Temporal changes in the incidence of cutaneous malignant melanoma (CMM) were examined in the San Franscisco-Oakland (California, United States) Metropolitan Statistical Area (MSA) between 1976 and 1987, using data from the population-based cancer registry. This analysis was conducted after the completion of a project designed to eliminate bias in the reporting of CMM due to changes in medical practice. The incidence of CMM is higher in the San Francisco-Oakland MSA than nationally. From 1976 through 1987, the incidence of invasive CMM increased from 9.8±0.9 to 16.5±1.1 per 100,000 (P=0.0001) among men and from 9.3±0.8 to 12.7±0.9 per 100,000 (P=0.001) among women. Age-specific, histologic-specific, and anatomic site-specific trends were also evaluated. The temporal patterns of CMM suggest that the recent increases are not accounted for solely by ascertainment bias due to reporting practices. The observed trends are consistent with early detection efforts and with changes in the prevalence of risk factors.
Similar content being viewed by others
References
1987 Annual Cancer Statistics Review-Including Cancer Trends: 1950–1085. Bethesda, MD: National Cancer Institute, 1988; NIH Pub. No. 88-2789.
Muir CS, Nectoux J. Time trends: malignant melanoma of the skin. In: Magnus K, ed. Trends in Cancer Incidence: Causes and Practical Implications. Washington DC: Hemisphere Publishing, 1982: 365–85.
Devesa SS, Silverman DT, Young JLJr, et al. Cancer incidence and mortality trends among whites in the United States, 1947–84. JNCI 1987; 79: 701–70.
Ries LAG, Hankey BF, Edwards BK, eds. Cancer Statistics Review 1973–87. Bethesda, MD: National Cancer Institute, 1990: NIH Pub. No. 90–2789.
World Health Organization. International Classification of Diseases for Oncology. Geneva: WHO, 1976.
International Agency for Research on Cancer and the National Cancer Institute. International Classification of Diseases for Oncology, Field Trial Edition. Lyon: IARC, 1986.
Sagebiel R. University of California Personal communication, 1991.
Greene MH, Clark WHJr, Tucker MA, et al. Acquired precursors of cutaneous malignant melanoma: the familial dysplastic nevus syndrome. N Engl J Med 1985; 312: 91–7.
Smith W. A Profile of Health and Disease in America. New York: Facts on File Publications, 1987.
Mihm MCJr, Fitzpatrick TB, Brown MML, Raker JW, Malt RA, Kaiser JS. Early detection of primary cutaneous malignant melanoma: a color atlas. N Engl J Med 1973; 289: 989–96.
Lee JAH. The melanoma epidemic thus far. Mayo Clin Proc 1990; 65: 1368–71.
Thorn M, Bergstrom R, Adami H-O, Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960–1984. Am J Epidemiol 1990; 132: 1066–77.
Young JL Jr, Percy CL, Asire AJ, eds. Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973–77. Natl Cancer Inst Monogr, 1981: 57: 20–25.
Additional information
Authors are at the Northern California Cancer Center, Alameda, CA, USA. Dr Holly is also with the Department of Health Research and Policy, Stanford University School of Medicine, and the Department of Epidemiology and Biostatistics, University of California, San Francisco, School of Medicine, USA. Address correspondence to Dr Horn-Ross, Northern California Cancer Center, 1420 Harbor Bay Pkwy, Suite 260, Alameda, CA 94501, USA. This research was supported by contract N01-CN-05224 from the Surveillance, Epidemiology, and End Results Program, National Cancer Institute, contract N01-CP-05681 from the National Cancer Institute, and subcontract 050E-8708 from the California Tumor Registry, California State Department of Health Services.
Rights and permissions
About this article
Cite this article
Horn-Ross, P.L., Holly, E.A., Brown, S.R. et al. Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco-Oakland MSA. Cancer Causes Control 2, 299–305 (1991). https://doi.org/10.1007/BF00051669
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00051669